{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:54:25Z","timestamp":1790823265907,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 4775A1\/1"],"award-info":[{"award-number":["RG 4775A1\/1"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0536-y","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T08:08:43Z","timestamp":1525334923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis"],"prefix":"10.1186","volume":"6","author":[{"given":"Iliana","family":"Michailidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Jongejan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen P.","family":"Vreijling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodosia","family":"Georgakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit B.","family":"de Wissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud A.","family":"Wolterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ruizendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngaisah","family":"Klar-Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita E.","family":"Grootemaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy I.","family":"Picavet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent M.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Paul","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole N.","family":"van der Wel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Ramaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Fluiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"536_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W (2015) HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics 31:166\u2013169. https:\/\/doi.org\/10.1093\/bioinformatics\/btu638","journal-title":"Bioinformatics"},{"key":"536_CR2","doi-asserted-by":"publisher","unstructured":"Arbore G, West EE, Spolski R, Robertson AAB, Klos A, Rheinheimer C, Dutow P, Woodruff TM, Yu ZX, O'Neill LA, Coll RC, Sher A, Leonard WJ, Kohl J, Monk P, Cooper MA, Arno M, Afzali B, Lachmann HJ, Cope AP, Mayer-Barber KD, Kemper C (2016) T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells. Science 352:aad1210. doi: https:\/\/doi.org\/10.1126\/science.aad1210","DOI":"10.1126\/science.aad1210"},{"key":"536_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","volume":"13","author":"N Bahia El Idrissi","year":"2016","unstructured":"Bahia El Idrissi N, Bosch S, Ramaglia V, Aronica E, Baas F, Troost D (2016) Complement activation at the motor end-plates in amyotrophic lateral sclerosis. J Neuroinflammation 13:72. https:\/\/doi.org\/10.1186\/s12974-016-0538-2","journal-title":"J Neuroinflammation"},{"key":"536_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00401-015-1404-5","volume":"129","author":"N Bahia El Idrissi","year":"2015","unstructured":"Bahia El Idrissi N, Das PK, Fluiter K, Rosa PS, Vreijling J, Troost D, Morgan BP, Baas F, Ramaglia V (2015) M. Leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator. Acta Neuropathol 129:653\u2013667. https:\/\/doi.org\/10.1007\/s00401-015-1404-5","journal-title":"Acta Neuropathol"},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0165-5728(90)90019-J","volume":"28","author":"D Baker","year":"1990","unstructured":"Baker D, O'Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL (1990) Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol 28:261\u2013270","journal-title":"J Neuroimmunol"},{"key":"536_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.21524","volume":"65","author":"MH Barnett","year":"2009","unstructured":"Barnett MH, Parratt JD, Cho ES, Prineas JW (2009) Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann Neurol 65:32\u201346. https:\/\/doi.org\/10.1002\/ana.21524","journal-title":"Ann Neurol"},{"key":"536_CR7","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1089\/neu.2016.4701","volume":"34","author":"PJC Biggins","year":"2017","unstructured":"Biggins PJC, Brennan FH, Taylor SM, Woodruff TM, Ruitenberg MJ (2017) The alternative receptor for complement component 5a, C5aR2, conveys neuroprotection in traumatic spinal cord injury. J Neurotrauma 34:2075\u20132085. https:\/\/doi.org\/10.1089\/neu.2016.4701","journal-title":"J Neurotrauma"},{"key":"536_CR8","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","volume":"35","author":"FH Brennan","year":"2015","unstructured":"Brennan FH, Gordon R, Lao HW, Biggins PJ, Taylor SM, Franklin RJ, Woodruff TM, Ruitenberg MJ (2015) The complement receptor C5aR controls acute inflammation and Astrogliosis following spinal cord injury. J Neurosci 35:6517\u20136531. https:\/\/doi.org\/10.1523\/JNEUROSCI.5218-14.2015","journal-title":"J Neurosci"},{"key":"536_CR10","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1073\/pnas.0812183106","volume":"106","author":"D Burger","year":"2009","unstructured":"Burger D, Molnarfi N, Weber MS, Brandt KJ, Benkhoucha M, Gruaz L, Chofflon M, Zamvil SS, Lalive PH (2009) Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci U S A 106:4355\u20134359. https:\/\/doi.org\/10.1073\/pnas.0812183106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"536_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12974-016-0605-8","volume":"13","author":"SM Burm","year":"2016","unstructured":"Burm SM, Peferoen LA, Zuiderwijk-Sick EA, Haanstra KG, t\u2019Hart BA, van der Valk P, Amor S, Bauer J, Bajramovic JJ (2016) Expression of IL-1beta in rhesus EAE and MS lesions is mainly induced in the CNS itself. J Neuroinflammation 13:138. https:\/\/doi.org\/10.1186\/s12974-016-0605-8","journal-title":"J Neuroinflammation"},{"issue":"Suppl 8","key":"536_CR12","doi-asserted-by":"publisher","first-page":"I28","DOI":"10.1016\/j.vaccine.2008.11.022","volume":"26","author":"MC Carroll","year":"2008","unstructured":"Carroll MC (2008) Complement and humoral immunity. Vaccine 26(Suppl 8):I28\u2013I33","journal-title":"Vaccine"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2133.1980.tb01682.x","volume":"103","author":"AC Chu","year":"1980","unstructured":"Chu AC, Smith N, MacDonald DM (1980) Evaluation of staining methods of resin embedded cutaneous tissue sections of mycosis fungoides. Br J Dermatol 103:607\u2013613","journal-title":"Br J Dermatol"},{"key":"536_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1517\/14728222.9.5.887","volume":"9","author":"JM Craft","year":"2005","unstructured":"Craft JM, Watterson DM, Van Eldik LJ (2005) Neuroinflammation: a potential therapeutic target. Expert Opin Ther Targets 9:887\u2013900. https:\/\/doi.org\/10.1517\/14728222.9.5.887","journal-title":"Expert Opin Ther Targets"},{"key":"536_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainres.2013.08.022","volume":"1535","author":"D Fandel","year":"2013","unstructured":"Fandel D, Wasmuht D, Avila-Martin G, Taylor JS, Galan-Arriero I, Mey J (2013) Spinal cord injury induced changes of nuclear receptors PPARalpha and LXRbeta and modulation with oleic acid\/albumin treatment. Brain Res 1535:89\u2013105. https:\/\/doi.org\/10.1016\/j.brainres.2013.08.022","journal-title":"Brain Res"},{"key":"536_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02918259","volume":"12","author":"J Figueroa","year":"1993","unstructured":"Figueroa J, Andreoni J, Densen P (1993) Complement deficiency states and meningococcal disease. Immunol Res 12:295\u2013311","journal-title":"Immunol Res"},{"key":"536_CR17","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.4049\/jimmunol.1302793","volume":"192","author":"K Fluiter","year":"2014","unstructured":"Fluiter K, Opperhuizen AL, Morgan BP, Baas F, Ramaglia V (2014) Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice. J Immunol 192:2339\u20132348. https:\/\/doi.org\/10.4049\/jimmunol.1302793","journal-title":"J Immunol"},{"key":"536_CR18","first-page":"608","volume":"64","author":"T Folaranmi","year":"2015","unstructured":"Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR, Centers for Disease C (2015) Use of serogroup B meningococcal vaccines in persons aged >\/=10 years at increased risk for serogroup B meningococcal disease: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep 64:608\u2013612","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"536_CR19","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4049\/jimmunol.163.5.2403","volume":"163","author":"R Furlan","year":"1999","unstructured":"Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L (1999) Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol 163:2403\u20132409","journal-title":"J Immunol"},{"key":"536_CR20","first-page":"31","volume":"150","author":"P Gasque","year":"1997","unstructured":"Gasque P, Singhrao SK, Neal JW, Gotze O, Morgan BP (1997) Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol 150:31\u201341","journal-title":"Am J Pathol"},{"key":"536_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","volume":"87","author":"RS Geary","year":"2015","unstructured":"Geary RS, Norris D, Yu R, Bennett CF (2015) Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv Drug Deliv Rev 87:46\u201351. https:\/\/doi.org\/10.1016\/j.addr.2015.01.008","journal-title":"Adv Drug Deliv Rev"},{"key":"536_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4049\/jimmunol.0904145","volume":"185","author":"D Gris","year":"2010","unstructured":"Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, Huang M, Schneider M, Miller SD, Ting JP (2010) NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol 185:974\u2013981. https:\/\/doi.org\/10.4049\/jimmunol.0904145","journal-title":"J Immunol"},{"key":"536_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","volume":"34","author":"G Guarda","year":"2011","unstructured":"Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I, Farlik M, Decker T, Du Pasquier RA, Romero P, Tschopp J (2011) Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34:213\u2013223. https:\/\/doi.org\/10.1016\/j.immuni.2011.02.006","journal-title":"Immunity"},{"key":"536_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo H, Callaway JB, Ting JP (2015) Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21:677\u2013687. https:\/\/doi.org\/10.1038\/nm.3893","journal-title":"Nat Med"},{"key":"536_CR25","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","volume":"23","author":"RF Guo","year":"2005","unstructured":"Guo RF, Ward PA (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23:821\u2013852. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115835","journal-title":"Annu Rev Immunol"},{"key":"536_CR26","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1212\/WNL.40.11.1735","volume":"40","author":"SL Hauser","year":"1990","unstructured":"Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40:1735\u20131739","journal-title":"Neurology"},{"key":"536_CR27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355:1233\u20131243. https:\/\/doi.org\/10.1056\/NEJMoa061648","journal-title":"N Engl J Med"},{"key":"536_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1084\/jem.193.1.111","volume":"193","author":"S Hisahara","year":"2001","unstructured":"Hisahara S, Yuan J, Momoi T, Okano H, Miura M (2001) Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination. J Exp Med 193:111\u2013122","journal-title":"J Exp Med"},{"key":"536_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1084\/jem.146.2.629","volume":"146","author":"MJ Hobart","year":"1977","unstructured":"Hobart MJ, Lachmann PJ, Calne RY (1977) C6: synthesis by the liver in vivo. J Exp Med 146:629\u2013630","journal-title":"J Exp Med"},{"key":"536_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/2051-5960-2-53","volume":"2","author":"G Ingram","year":"2014","unstructured":"Ingram G, Loveless S, Howell OW, Hakobyan S, Dancey B, Harris CL, Robertson NP, Neal JW, Morgan BP (2014) Complement activation in multiple sclerosis plaques: an immunohistochemical analysis. Acta Neuropathol Commun 2:53. https:\/\/doi.org\/10.1186\/2051-5960-2-53","journal-title":"Acta Neuropathol Commun"},{"key":"536_CR31","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/nn.4421","volume":"19","author":"M Inoue","year":"2016","unstructured":"Inoue M, Chen PH, Siecinski S, Li QJ, Liu C, Steinman L, Gregory SG, Benner E, Shinohara ML (2016) An interferon-beta-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage. Nat Neurosci 19:1599\u20131609. https:\/\/doi.org\/10.1038\/nn.4421","journal-title":"Nat Neurosci"},{"key":"536_CR32","doi-asserted-by":"publisher","first-page":"10480","DOI":"10.1073\/pnas.1201836109","volume":"109","author":"M Inoue","year":"2012","unstructured":"Inoue M, Williams KL, Gunn MD, Shinohara ML (2012) NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 109:10480\u201310485. https:\/\/doi.org\/10.1073\/pnas.1201836109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"536_CR33","doi-asserted-by":"publisher","unstructured":"Inoue M, Williams KL, Oliver T, Vandenabeele P, Rajan JV, Miao EA, Shinohara ML (2012) Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci signal 5:ra38. https:\/\/doi.org\/10.1126\/scisignal.2002767","DOI":"10.1126\/scisignal.2002767"},{"key":"536_CR34","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1038\/ncomms8360","volume":"6","author":"M Ito","year":"2015","unstructured":"Ito M, Shichita T, Okada M, Komine R, Noguchi Y, Yoshimura A, Morita R (2015) Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nat Commun 6:7360. https:\/\/doi.org\/10.1038\/ncomms8360","journal-title":"Nat Commun"},{"key":"536_CR35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/NEN.0b013e3181a41d23","volume":"68","author":"SJ Jackson","year":"2009","unstructured":"Jackson SJ, Lee J, Nikodemova M, Fabry Z, Duncan ID (2009) Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. J Neuropathol Exp Neurol 68:616\u2013625. https:\/\/doi.org\/10.1097\/NEN.0b013e3181a41d23","journal-title":"J Neuropathol Exp Neurol"},{"key":"536_CR36","doi-asserted-by":"publisher","first-page":"15811","DOI":"10.1523\/JNEUROSCI.4088-10.2010","volume":"30","author":"S Jha","year":"2010","unstructured":"Jha S, Srivastava SY, Brickey WJ, Iocca H, Toews A, Morrison JP, Chen VS, Gris D, Matsushima GK, Ting JP (2010) The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci 30:15811\u201315820. https:\/\/doi.org\/10.1523\/JNEUROSCI.4088-10.2010","journal-title":"J Neurosci"},{"key":"536_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm820","volume":"9","author":"SB Joseph","year":"2003","unstructured":"Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9:213\u2013219. https:\/\/doi.org\/10.1038\/nm820","journal-title":"Nat Med"},{"key":"536_CR38","first-page":"2019","volume":"150","author":"KS Kilgore","year":"1997","unstructured":"Kilgore KS, Schmid E, Shanley TP, Flory CM, Maheswari V, Tramontini NL, Cohen H, Ward PA, Friedl HP, Warren JS (1997) Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 150:2019\u20132031","journal-title":"Am J Pathol"},{"key":"536_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL (2015) HISAT: a fast spliced aligner with low memory requirements. Nat Methods 12:357\u2013360. https:\/\/doi.org\/10.1038\/nmeth.3317","journal-title":"Nat Methods"},{"key":"536_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molimm.2016.06.004","volume":"76","author":"J Kotimaa","year":"2016","unstructured":"Kotimaa J, Klar-Mohammad N, Gueler F, Schilders G, Jansen A, Rutjes H, Daha MR, van Kooten C (2016) Sex matters: systemic complement activity of female C57BL\/6J and BALB\/cJ mice is limited by serum terminal pathway components. Mol Immunol 76:13\u201321. https:\/\/doi.org\/10.1016\/j.molimm.2016.06.004","journal-title":"Mol Immunol"},{"key":"536_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer A, Green J, Pollard J Jr, Tugendreich S (2014) Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30:523\u2013530. https:\/\/doi.org\/10.1093\/bioinformatics\/btt703","journal-title":"Bioinformatics"},{"key":"536_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2006.08.016","volume":"259","author":"H Lassmann","year":"2007","unstructured":"Lassmann H (2007) Multiple sclerosis: is there neurodegeneration independent from inflammation? J Neurol Sci 259:3\u20136. https:\/\/doi.org\/10.1016\/j.jns.2006.08.016","journal-title":"J Neurol Sci"},{"key":"536_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/9781118732748.ch1","volume-title":"Neuroinflammation: new insights into beneficial and detrimental functions","author":"H Lassmann","year":"2015","unstructured":"Lassmann H (2015) Immune response in the human central nervous system in multiple sclerosis and stroke. In: David S (ed) Neuroinflammation: new insights into beneficial and detrimental functions, 1st edn. John Wiley & Sons, Inc, Hoboken. https:\/\/doi.org\/10.1002\/9781118732748.ch1","edition":"1"},{"key":"536_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann H, Bradl M (2017) Multiple sclerosis: experimental models and reality. Acta Neuropathol 133:223\u2013244. https:\/\/doi.org\/10.1007\/s00401-016-1631-4","journal-title":"Acta Neuropathol"},{"key":"536_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4049\/jimmunol.1300489","volume":"191","author":"F Laudisi","year":"2013","unstructured":"Laudisi F, Spreafico R, Evrard M, Hughes TR, Mandriani B, Kandasamy M, Morgan BP, Sivasankar B, Mortellaro A (2013) Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1beta release. J Immunol 191:1006\u20131010. https:\/\/doi.org\/10.4049\/jimmunol.1300489","journal-title":"J Immunol"},{"key":"536_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/sj.icb.7100166","volume":"86","author":"H Lee","year":"2008","unstructured":"Lee H, Whitfeld PL, Mackay CR (2008) Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 86:153\u2013160. https:\/\/doi.org\/10.1038\/sj.icb.7100166","journal-title":"Immunol Cell Biol"},{"key":"536_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/bph.13730","volume":"174","author":"JD Lee","year":"2017","unstructured":"Lee JD, Kumar V, Fung JN, Ruitenberg MJ, Noakes PG, Woodruff TM (2017) Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Br J Pharmacol 174:689\u2013699. https:\/\/doi.org\/10.1111\/bph.13730","journal-title":"Br J Pharmacol"},{"key":"536_CR48","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"536_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature04515","volume":"440","author":"S Mariathasan","year":"2006","unstructured":"Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228\u2013232. https:\/\/doi.org\/10.1038\/nature04515","journal-title":"Nature"},{"key":"536_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1620\/tjem.174.269","volume":"174","author":"PL McGeer","year":"1994","unstructured":"McGeer PL, Klegeris A, Walker DG, Yasuhara O, McGeer EG (1994) Pathological proteins in senile plaques. Tohoku J Exp Med 174:269\u2013277","journal-title":"Tohoku J Exp Med"},{"key":"536_CR51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4049\/jimmunol.168.1.458","volume":"168","author":"RJ Mead","year":"2002","unstructured":"Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP (2002) The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol 168:458\u2013465","journal-title":"J Immunol"},{"key":"536_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/1352458509355068","volume":"16","author":"J Mellergard","year":"2010","unstructured":"Mellergard J, Edstrom M, Vrethem M, Ernerudh J, Dahle C (2010) Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid. Mult Scler 16:208\u2013217. https:\/\/doi.org\/10.1177\/1352458509355068","journal-title":"Mult Scler"},{"key":"536_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044739","volume":"7","author":"J Mellergard","year":"2012","unstructured":"Mellergard J, Tisell A, Dahlqvist Leinhard O, Blystad I, Landtblom AM, Blennow K, Olsson B, Dahle C, Ernerudh J, Lundberg P, Vrethem M (2012) Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis. PLoS One 7:e44739. https:\/\/doi.org\/10.1371\/journal.pone.0044739","journal-title":"PLoS One"},{"key":"536_CR54","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/glia.23090","volume":"65","author":"I Michailidou","year":"2017","unstructured":"Michailidou I, Naessens DM, Hametner S, Guldenaar W, Kooi EJ, Geurts JJ, Baas F, Lassmann H, Ramaglia V (2017) Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: implication for disease pathogenesis. Glia 65:264\u2013277. https:\/\/doi.org\/10.1002\/glia.23090","journal-title":"Glia"},{"key":"536_CR55","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ana.24398","volume":"77","author":"I Michailidou","year":"2015","unstructured":"Michailidou I, Willems JG, Kooi EJ, van Eden C, Gold SM, Geurts JJ, Baas F, Huitinga I, Ramaglia V (2015) Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann Neurol 77:1007\u20131026. https:\/\/doi.org\/10.1002\/ana.24398","journal-title":"Ann Neurol"},{"key":"536_CR56","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2249.2004.02646.x","volume":"138","author":"BP Morgan","year":"2004","unstructured":"Morgan BP, Griffiths M, Khanom H, Taylor SM, Neal JW (2004) Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats. Clin Exp Immunol 138:430\u2013438. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02646.x","journal-title":"Clin Exp Immunol"},{"key":"536_CR57","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrd4657","volume":"14","author":"BP Morgan","year":"2015","unstructured":"Morgan BP, Harris CL (2015) Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov 14:857\u2013877. https:\/\/doi.org\/10.1038\/nrd4657","journal-title":"Nat Rev Drug Discov"},{"key":"536_CR58","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.4049\/jimmunol.172.9.5702","volume":"172","author":"T Niculescu","year":"2004","unstructured":"Niculescu T, Weerth S, Niculescu F, Cudrici C, Rus V, Raine CS, Shin ML, Rus H (2004) Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis. J Immunol 172:5702\u20135706","journal-title":"J Immunol"},{"key":"536_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0143-4160(94)90061-2","volume":"15","author":"JC Papadimitriou","year":"1994","unstructured":"Papadimitriou JC, Phelps PC, Shin ML, Smith MW, Trump BF (1994) Effects of Ca2+ deregulation on mitochondrial membrane potential and cell viability in nucleated cells following lytic complement attack. Cell Calcium 15:217\u2013227","journal-title":"Cell Calcium"},{"key":"536_CR60","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.molimm.2014.10.008","volume":"63","author":"E Peelen","year":"2015","unstructured":"Peelen E, Damoiseaux J, Muris AH, Knippenberg S, Smolders J, Hupperts R, Thewissen M (2015) Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis. Mol Immunol 63:521\u2013529. https:\/\/doi.org\/10.1016\/j.molimm.2014.10.008","journal-title":"Mol Immunol"},{"key":"536_CR61","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/cei.12595","volume":"180","author":"V Ramaglia","year":"2015","unstructured":"Ramaglia V, Jackson SJ, Hughes TR, Neal JW, Baker D, Morgan BP (2015) Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. Clin Exp Immunol 180:432\u2013441. https:\/\/doi.org\/10.1111\/cei.12595","journal-title":"Clin Exp Immunol"},{"key":"536_CR62","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.molimm.2009.01.017","volume":"46","author":"V Ramaglia","year":"2009","unstructured":"Ramaglia V, King RH, Morgan BP, Baas F (2009) Deficiency of the complement regulator CD59a exacerbates Wallerian degeneration. Mol Immunol 46:1892\u20131896. https:\/\/doi.org\/10.1016\/j.molimm.2009.01.017","journal-title":"Mol Immunol"},{"key":"536_CR63","doi-asserted-by":"publisher","first-page":"7663","DOI":"10.1523\/JNEUROSCI.5623-06.2007","volume":"27","author":"V Ramaglia","year":"2007","unstructured":"Ramaglia V, King RH, Nourallah M, Wolterman R, de Jonge R, Ramkema M, Vigar MA, van der Wetering S, Morgan BP, Troost D, Baas F (2007) The membrane attack complex of the complement system is essential for rapid Wallerian degeneration. J Neurosci 27:7663\u20137672. https:\/\/doi.org\/10.1523\/JNEUROSCI.5623-06.2007","journal-title":"J Neurosci"},{"key":"536_CR64","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neulet.2005.08.022","volume":"390","author":"R Reiman","year":"2005","unstructured":"Reiman R, Campos Torres A, Martin BK, Ting JP, Campbell IL, Barnum SR (2005) Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis. Neurosci Lett 390:134\u2013138. https:\/\/doi.org\/10.1016\/j.neulet.2005.08.022","journal-title":"Neurosci Lett"},{"key":"536_CR65","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/1521-4141(200204)32:4<1157::AID-IMMU1157>3.0.CO;2-M","volume":"32","author":"R Reiman","year":"2002","unstructured":"Reiman R, Gerard C, Campbell IL, Barnum SR (2002) Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis. Eur J Immunol 32:1157\u20131163. https:\/\/doi.org\/10.1002\/1521-4141(200204).%2032:4&%2360;1157::AID-IMMU1157&%2362;3.0.CO;2-M","journal-title":"Eur J Immunol"},{"key":"536_CR66","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785\u2013797. https:\/\/doi.org\/10.1038\/ni.1923","journal-title":"Nat Immunol"},{"key":"536_CR67","doi-asserted-by":"publisher","first-page":"11541","DOI":"10.1038\/ncomms11541","volume":"7","author":"F Ronchi","year":"2016","unstructured":"Ronchi F, Basso C, Preite S, Reboldi A, Baumjohann D, Perlini L, Lanzavecchia A, Sallusto F (2016) Experimental priming of encephalitogenic Th1\/Th17 cells requires pertussis toxin-driven IL-1beta production by myeloid cells. Nat Commun 7:11541. https:\/\/doi.org\/10.1038\/ncomms11541","journal-title":"Nat Commun"},{"key":"536_CR68","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1742-2094-11-32","volume":"11","author":"S Rossi","year":"2014","unstructured":"Rossi S, Studer V, Motta C, Germani G, Macchiarulo G, Buttari F, Mancino R, Castelli M, De Chiara V, Weiss S, Martino G, Furlan R, Centonze D (2014) Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis. J Neuroinflammation 11:32. https:\/\/doi.org\/10.1186\/1742-2094-11-32","journal-title":"J Neuroinflammation"},{"key":"536_CR69","doi-asserted-by":"publisher","first-page":"14319","DOI":"10.1073\/pnas.1513698112","volume":"112","author":"MM Ruseva","year":"2015","unstructured":"Ruseva MM, Ramaglia V, Morgan BP, Harris CL (2015) An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice. Proc Natl Acad Sci U S A 112:14319\u201314324. https:\/\/doi.org\/10.1073\/pnas.1513698112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"536_CR70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/cne.10858","volume":"465","author":"CB Saper","year":"2003","unstructured":"Saper CB, Sawchenko PE (2003) Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 465:161\u2013163. https:\/\/doi.org\/10.1002\/cne.10858","journal-title":"J Comp Neurol"},{"key":"536_CR71","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/mrm.21289","volume":"58","author":"AE Schellenberg","year":"2007","unstructured":"Schellenberg AE, Buist R, Yong VW, Del Bigio MR, Peeling J (2007) Magnetic resonance imaging of blood-spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitis. Magn Reson Med 58:298\u2013305. https:\/\/doi.org\/10.1002\/mrm.21289","journal-title":"Magn Reson Med"},{"key":"536_CR72","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2014.02.014","volume":"270","author":"D Seppi","year":"2014","unstructured":"Seppi D, Puthenparampil M, Federle L, Ruggero S, Toffanin E, Rinaldi F, Perini P, Gallo P (2014) Cerebrospinal fluid IL-1beta correlates with cortical pathology load in multiple sclerosis at clinical onset. J Neuroimmunol 270:56\u201360. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.02.014","journal-title":"J Neuroimmunol"},{"key":"536_CR73","doi-asserted-by":"publisher","first-page":"9301","DOI":"10.1523\/JNEUROSCI.1418-07.2007","volume":"27","author":"SS Shaftel","year":"2007","unstructured":"Shaftel SS, Carlson TJ, Olschowka JA, Kyrkanides S, Matousek SB, O'Banion MK (2007) Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci 27:9301\u20139309. https:\/\/doi.org\/10.1523\/JNEUROSCI.1418-07.2007","journal-title":"J Neurosci"},{"key":"536_CR74","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.4049\/jimmunol.1000217","volume":"184","author":"PJ Shaw","year":"2010","unstructured":"Shaw PJ, Lukens JR, Burns S, Chi H, McGargill MA, Kanneganti TD (2010) Cutting edge: critical role for PYCARD\/ASC in the development of experimental autoimmune encephalomyelitis. J Immunol 184:4610\u20134614. https:\/\/doi.org\/10.4049\/jimmunol.1000217","journal-title":"J Immunol"},{"key":"536_CR75","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/brain\/aww314","volume":"140","author":"A Stokowska","year":"2017","unstructured":"Stokowska A, Atkins AL, Moran J, Pekny T, Bulmer L, Pascoe MC, Barnum SR, Wetsel RA, Nilsson JA, Dragunow M, Pekna M (2017) Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia. Brain 140:353\u2013369. https:\/\/doi.org\/10.1093\/brain\/aww314","journal-title":"Brain"},{"key":"536_CR76","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","volume":"28","author":"DS Straus","year":"2007","unstructured":"Straus DS, Glass CK (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28:551\u2013558. https:\/\/doi.org\/10.1016\/j.it.2007.09.003","journal-title":"Trends Immunol"},{"key":"536_CR77","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.4049\/jimmunol.168.9.4293","volume":"168","author":"GT Tran","year":"2002","unstructured":"Tran GT, Hodgkinson SJ, Carter N, Killingsworth M, Spicer ST, Hall BM (2002) Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords. J Immunol 168:4293\u20134300","journal-title":"J Immunol"},{"key":"536_CR78","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1242\/jcs.124388","volume":"126","author":"K Triantafilou","year":"2013","unstructured":"Triantafilou K, Hughes TR, Triantafilou M, Morgan BP (2013) The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci 126:2903\u20132913. https:\/\/doi.org\/10.1242\/jcs.124388","journal-title":"J Cell Sci"},{"key":"536_CR79","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/imm.12556","volume":"147","author":"M Triantafilou","year":"2016","unstructured":"Triantafilou M, Hughes TR, Morgan BP, Triantafilou K (2016) Complementing the inflammasome. Immunology 147:152\u2013164. https:\/\/doi.org\/10.1111\/imm.12556","journal-title":"Immunology"},{"key":"536_CR80","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/nm.2543","volume":"17","author":"Q Wang","year":"2011","unstructured":"Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM, Hwang I, Wong HH, Punzi L, Encarnacion A, Shamloo M, Goodman SB, Wyss-Coray T, Goldring SR, Banda NK, Thurman JM, Gobezie R, Crow MK, Holers VM, Lee DM, Robinson WH (2011) Identification of a central role for complement in osteoarthritis. Nat Med 17:1674\u20131679. https:\/\/doi.org\/10.1038\/nm.2543","journal-title":"Nat Med"},{"key":"536_CR81","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00109-009-0442-7","volume":"87","author":"PA Ward","year":"2009","unstructured":"Ward PA (2009) Functions of C5a receptors. J Mol Med (Berl) 87:375\u2013378. https:\/\/doi.org\/10.1007\/s00109-009-0442-7","journal-title":"J Mol Med (Berl)"},{"key":"536_CR82","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12974-016-0611-x","volume":"13","author":"LM Watkins","year":"2016","unstructured":"Watkins LM, Neal JW, Loveless S, Michailidou I, Ramaglia V, Rees MI, Reynolds R, Robertson NP, Morgan BP, Howell OW (2016) Complement is activated in progressive multiple sclerosis cortical grey matter lesions. J Neuroinflammation 13:161. https:\/\/doi.org\/10.1186\/s12974-016-0611-x","journal-title":"J Neuroinflammation"},{"key":"536_CR83","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0002-9440(10)63466-9","volume":"163","author":"SH Weerth","year":"2003","unstructured":"Weerth SH, Rus H, Shin ML, Raine CS (2003) Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. Am J Pathol 163:1069\u20131080. https:\/\/doi.org\/10.1016\/S0002-9440(10)63466-9","journal-title":"Am J Pathol"},{"key":"536_CR84","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.trsl.2014.10.010","volume":"165","author":"EK Wong","year":"2015","unstructured":"Wong EK, Kavanagh D (2015) Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Transl Res 165:306\u2013320. https:\/\/doi.org\/10.1016\/j.trsl.2014.10.010","journal-title":"Transl Res"},{"key":"536_CR85","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1096\/fj.05-5814com","volume":"20","author":"TM Woodruff","year":"2006","unstructured":"Woodruff TM, Crane JW, Proctor LM, Buller KM, Shek AB, de Vos K, Pollitt S, Williams HM, Shiels IA, Monk PN, Taylor SM (2006) Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J 20:1407\u20131417. https:\/\/doi.org\/10.1096\/fj.05-5814com","journal-title":"FASEB J"},{"key":"536_CR86","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2249.1991.tb05656.x","volume":"83","author":"R Wurzner","year":"1991","unstructured":"Wurzner R, Orren A, Potter P, Morgan BP, Ponard D, Spath P, Brai M, Schulze M, Happe L, Gotze O (1991) Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals. Clin Exp Immunol 83:430\u2013437","journal-title":"Clin Exp Immunol"},{"key":"536_CR87","doi-asserted-by":"publisher","first-page":"8193932","DOI":"10.1155\/2017\/8193932","volume":"2017","author":"T Zhang","year":"2017","unstructured":"Zhang T, Garstka MA, Li K (2017) The controversial C5a receptor C5aR2: its role in health and disease. J Immunol Res 2017:8193932. https:\/\/doi.org\/10.1155\/2017\/8193932","journal-title":"J Immunol Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0536-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0536-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0536-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T11:28:11Z","timestamp":1693654091000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0536-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0536-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"30 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were approved by the Academic Medical Center Animal Ethics Committee and complied with the Dutch national policy on humane care and the use of laboratory animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"FB, KF and VR are the inventors of patents that describe the use of inhibitors of the terminal complement pathway for therapeutic purposes; they are co-founders of Regenesance BV. FB. is founder of Complement Pharma BV.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"36"}}